多元赋能，广中医深圳医院得壹中医药创新转化中心启用

Core Viewpoint - The establishment of the "De Yi Traditional Chinese Medicine Innovation and Transformation Center" marks a significant step in Shenzhen's efforts to develop a leading TCM innovation city and a strategic platform for the inheritance and innovation of TCM in the Guangdong-Hong Kong-Macao Greater Bay Area [1][2]. Group 1: Challenges and Objectives - The TCM sector faces challenges such as insufficient inheritance, lack of innovation, and ineffective transformation mechanisms [2]. - Shenzhen, despite its advantages, still lags behind cities like Beijing and Shanghai in TCM innovation and patent output [2]. - The center aims to leverage the unique policies and advantages of the He Tao Cooperation Zone to explore new paths for TCM modernization, industrialization, and internationalization [2]. Group 2: Development Framework - The center's construction is a systematic restructuring rather than mere spatial expansion, with a clear top-level design [3]. - It establishes a "one-three-five-seven" development system, focusing on creating an international TCM innovation transformation platform [3]. - The three platforms include a TCM health product drug transformation platform, an intelligent TCM equipment system platform, and a Hong Kong-Shenzhen TCM cooperation exchange platform [3]. Group 3: Core Advantages and Focus Areas - The center will focus on major chronic diseases such as cardiovascular diseases, diabetes, tumors, and respiratory diseases, utilizing the clinical foundation of Guangzhou University of Chinese Medicine Shenzhen Hospital [4]. - It aims to enhance technology research and product innovation through multi-party collaboration and complementary advantages [4]. Group 4: Systematic Support and International Collaboration - The center will establish a comprehensive support system from laboratory to market, including a professional concept verification and small-scale testing base [5]. - A technical transfer team will provide one-stop services covering intellectual property, outcome evaluation, and commercial connections [5]. - The center will promote AI technology integration and international collaboration, connecting global resources to advance TCM innovation [5]. Group 5: Collaborative Mechanisms and New Business Models - The center will promote cross-border joint research mechanisms and resource sharing among universities, research institutions, and enterprises in the Greater Bay Area [6]. - It will explore new business models combining TCM, health care, and tourism, developing cross-border health tourism products [7]. Group 6: Initial Achievements and Future Outlook - The center has already made progress in areas such as in-hospital formulation development, intelligent TCM equipment research, and patent transformation [8]. - It has signed cooperation agreements with over 20 domestic and international institutions and enterprises, establishing a diversified ecosystem for industry-university-research collaboration [8]. - The center aims to build a national-level TCM inheritance and innovation center, creating a virtuous cycle of research, transformation, industry, and promotion [8].